Therefore, IL-36α may exhibit bidirectional functions in ovarian cancer carcinogenesis, both anti-tumor and pro-tumor, and this role may depend on the type of ovarian cancer and the degree of histological differentiation, which requires further in-depth analysis. This evidence concerns the gene IL36A and ovarian carcinoma.